Chatterjee J — Endo Lab

preprint 2026

MicroRNA-Mediated Rewiring of the PI3K–AKT–mTOR Axis Reveals Divergent Regulatory Networks and Metabolic Vulnerabilities in Endometriosis-Associated Ovarian Cancers (EAOCs)

·doi:10.20944/preprints202607.1410.v1

Background: Endometriosis-associated ovarian cancers (EAOCs), including clear cell (OCCC) and endometrioid (EnOC) subtypes, frequently activate the PI3K/AKT/mTOR signaling axis. While genomic aberrations are well documented, the coordinate…

2026

Robotic-integrated intraoperative ultrasound for excision of accessory cavitated uterine malformation (ACUM): an innovative surgical technique.

Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08395-2

BackgroundAccessory cavitated uterine mass (ACUM) is a rare Mullerian anomaly that predominantly affects young women, presenting with refractory dysmenorrhea. Despite 3D ultrasound and MRI being the gold standard for diagnosis, diagnostic d…

2024

In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.

Cancers ·doi:10.3390/cancers16030582

BackgroundProtein Tyrosine Phosphatase Receptor Type D (PTPRD) is involved in the regulation of cell growth, differentiation, and oncogenic transformation, as well as in brain development. PTPRD also mediates the effects of asprosin, which …

article 2018

Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry

International journal of molecular medicine ·doi:10.3892/ijmm.2018.3967

Endometriosis is a well‑known risk factor for ovarian cancer. The genetic changes that characterise endometriosis are poorly understood; however, the mechanistic target of rapamycin (mTOR) pathway is involved. In this study, we investigated…

letter 2012

Adenomyosis and infertility

Reproductive biomedicine online ·doi:10.1016/j.rbmo.2012.02.013